Vanda Pharmaceuticals, Inc. (VNDA) Misses Q1 EPS by 49c
Tweet
Share
E-mailGet Alerts VNDA Hot Sheet
Price: $5.42 +0.37%
EPS Growth %: -60.5%
Financial Fact:
Cost of sales, product: 6.99M
Today's EPS Names:
RCBC, GASS, YSG, More
EPS Growth %: -60.5%
Financial Fact:
Cost of sales, product: 6.99M
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) reported Q1 EPS of ($0.79), $0.49 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $8.75 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals, Inc. (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
- Dell Technologies (DELL) Tops Q2 EPS by $2.17, Offers Guidance
- Berenberg Starts Avio (AVIO:IM) at Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
